ICD-10 Specific code U04.9: Severe acute respiratory syndrome, unspecified
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Severe acute respiratory syndrome, unspecified |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | XXII | Codes for special purposes | |
| 2 | U00-U49 | Provisional assignment of new diseases of uncertain etiology | |
| 3 | U04 | Severe acute respiratory syndrome [SARS] | |
| 4 | U04.9 | Severe acute respiratory syndrome, unspecified |
Indicated medicines
| Active Ingredient |
|---|
|
Bacterial lysates are powerful inducers of a specific locoregional immune response that significantly enhance the concentration of antibodies directed to antigenic structures of bacteria most commonly observed during infections of the upper respiratory tract. |
|
|
|
Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines. |
|
Piperacillin is a broad-spectrum, semisynthetic penicillin. Piperacillin exerts bactericidal activity by inhibition of both septum and cell-wall synthesis. |
|
Sultamicillin is the tosylate salt of the double ester of sulbactam plus ampicillin. Sulbactam is a semisynthetic beta-lactamase inhibitor which, in combination with ampicillin, extends the antibacterial activity of the latter to include some beta-lactamase-producing strains of bacteria that would otherwise be resistant. |
|
Ticarcillin disrupts bacterial cell wall development by inhibiting peptidoglycan synthesis and/or by interacting with penicillin-binding proteins. |